Faro Health

Faro is an AI-powered platform purpose-built for clinical development in the biopharma industry. Designed to accelerate and improve the quality of clinical studies, Faro supports teams across the full lifecycle of study design and execution, from protocol optimization through to study startup. The platform is trusted by leading biopharma organizations seeking to reduce costs, minimize patient burden, and streamline complex trial processes.

By combining real-time data insights, intelligent document authoring, and workflow automation, Faro enables clinical teams to make faster, more informed decisions. The platform has demonstrated measurable impact, with users identifying over $300 million in potential cost savings, avoiding more than 200,000 potential patient hours, and eliminating over 1,500 potential research visit units (RVUs).

Core Platform Modules

• Study Design: Optimize clinical protocols using data-driven insights and real-time feedback, enabling teams to evaluate and refine schedules of assessment (SoA) and reduce trial complexity before study startup.
• Document Authoring: Generate high-quality protocol drafts in minutes using AI, significantly reducing the time and effort required to produce study documentation.
• Workflow Automation: Accelerate study startup through automated EDC (Electronic Data Capture) builds and other process automations, reducing manual effort and operational delays.

Key Capabilities and Impact

• End-to-end support for intelligent study design and execution within a single integrated platform.
• Real-time quantification of the impact of protocol changes, providing immediate feedback to clinical teams and sponsors.
• Demonstrated ability to identify substantial potential savings in participant time, site staff time, costs, and trial complexity, as validated in peer-reviewed research published in Therapeutic Innovation & Regulatory Science (2024).
• Recognized as a winner in the TransCelerate Protocol Review Challenge, highlighting the platform's innovation in protocol development.

Industry Recognition and Thought Leadership

• Faro has been recognized by TransCelerate for its contributions to protocol review and clinical development innovation.
• The company actively publishes insights on topics including the FDA's AI initiatives, data practices in clinical development, and the evolving role of AI in scaling life sciences operations.
• Faro's platform and brand have undergone continued evolution, reflecting its commitment to advancing AI capabilities for clinical teams.

Faro serves the world's leading biopharma teams, offering a proven, AI-driven approach to reducing the time, cost, and complexity of clinical development while improving the quality and efficiency of study design and execution.